EUVIMEDEUVIMED entdecken
Open Access

Response-Adaptive Randomization in Clinical Trials: From Myths to Practical Considerations

David S Robertson, Kim May Lee, Boryana C López-Kolkovska, Sofía S Villar

Statistical Science · 01.05.2023 · 38 (2) · 185-208

DOI: 10.1214/22-sts865 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistical Science, erschienen am 01.05.2023. Verfasst von David S Robertson und 3 weiteren Autor:innen. Beteiligte Einrichtung: MRC Biostatistics Unit, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 0SR, United Kingdom. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Response-Adaptive Randomization (RAR) is part of a wider class of data-dependent sampling algorithms, for which clinical trials are typically used as a motivating application. In that context, patient allocation to treatments is determined by randomization probabilities that change based on the accrued response data in order to achieve experimental goals. RAR has received abundant theoretical attention from the biostatistical literature since the 1930s and has been the subject of numerous debates. In the last decade, it has received renewed consideration from the applied and methodological communities, driven by well-known practical examples and its widespread use in machine learning. Papers on the subject present different views on its usefulness, and these are not easy to reconcile. This work aims to address this gap by providing a broad, balanced and fresh review of methodological and practical issues to consider when debating the use of RAR in clinical trials.

Schlagwörter

Stichwörter der Autor:innen

ethicspatient allocationpowersample size imbalancetime trendstype I error control

Autor:innen und Institutionen

  • MRC Biostatistics Unit, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 0SR, United Kingdom.
  • MRC Biostatistics Unit.
  • MRC Biostatistics Unit and is currently working at AstraZeneca.

Förderung

  • Medical Research Council

Zitieren

APA

Robertson, D. S., Lee, K. M., López-Kolkovska, B. C., & Villar, S. S. (2023). Response-Adaptive Randomization in Clinical Trials: From Myths to Practical Considerations. Statistical Science, 38(2), 185-208. https://doi.org/10.1214/22-sts865

Vancouver

Robertson DS, Lee KM, López-Kolkovska BC, Villar SS. Response-Adaptive Randomization in Clinical Trials: From Myths to Practical Considerations. Statistical Science. 2023;38(2):185-208. doi:10.1214/22-sts865

BibTeX
@article{Robertson2023,
  author = {Robertson, David S and Lee, Kim May and López-Kolkovska, Boryana C and Villar, Sofía S},
  title = {Response-Adaptive Randomization in Clinical Trials: From Myths to Practical Considerations},
  journal = {Statistical Science},
  year = {2023},
  volume = {38},
  number = {2},
  pages = {185--208},
  doi = {10.1214/22-sts865}
}
Kostenlos starten →